Phase1a, Dose-escalation Study of NNI-362 in Healthy Aged Volunteers
Clinical trial NCT04074837 · COMPLETED
Trial details
- NCT number
- NCT04074837
- Sponsor
- Neuronascent, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-01
- Primary completion
- 2021-07-31
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.